Cargando…
The antipsychotic-like effects of the mGlu group III orthosteric agonist, LSP1-2111, involves 5-HT(1A) signalling
RATIONALE: Several studies have suggested that modulation of the glutamatergic system via metabotropic glutamate receptors (mGlu) could be a new way to achieve antipsychotic-like activity. LSP1-2111, the group III mGlu receptor orthosteric agonist, with a high affinity towards mGlu(4) receptors, was...
Autores principales: | Wierońska, Joanna M., Acher, Francine C., Sławińska, Anna, Gruca, Piotr, Łasoń-Tyburkiewicz, Magdalena, Papp, Mariusz, Pilc, Andrzej |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3663209/ https://www.ncbi.nlm.nih.gov/pubmed/23474845 http://dx.doi.org/10.1007/s00213-013-3005-0 |
Ejemplares similares
-
Involvement of GABA(B) Receptor Signaling in Antipsychotic-like Action of the Novel Orthosteric Agonist of the mGlu(4) Receptor, LSP4-2022
por: Woźniak, Monika, et al.
Publicado: (2016) -
Opposing efficacy of group III mGlu receptor activators, LSP1-2111 and AMN082, in animal models of positive symptoms of schizophrenia
por: Wierońska, Joanna M., et al.
Publicado: (2011) -
The antipsychotic-like effects in rodents of the positive allosteric modulator Lu AF21934 involve 5-HT(1A) receptor signaling: mechanistic studies
por: Wierońska, Joanna M., et al.
Publicado: (2014) -
Negative Allosteric Modulators of mGlu(7) Receptor as Putative Antipsychotic Drugs
por: Cieślik, Paulina, et al.
Publicado: (2018) -
Mutual activation of glutamatergic mGlu(4) and muscarinic M(4) receptors reverses schizophrenia-related changes in rodents
por: Cieślik, Paulina, et al.
Publicado: (2018)